79 related articles for article (PubMed ID: 10900226)
1. Hydroxyprolylserine derivatives JBP923 and JBP485 exhibit the antihepatitis activities after gastrointestinal absorption in rats.
Liu KX; Kato Y; Kaku TI; Santa T; Imai K; Yagi A; Ishizu T; Sugiyama Y
J Pharmacol Exp Ther; 2000 Aug; 294(2):510-5. PubMed ID: 10900226
[TBL] [Abstract][Full Text] [Related]
2. Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo.
Liu Z; Wang C; Liu Q; Meng Q; Cang J; Mei L; Kaku T; Liu K
Peptides; 2011 Apr; 32(4):747-54. PubMed ID: 21262302
[TBL] [Abstract][Full Text] [Related]
3. Bioactivatable Pseudotripeptidization of Cyclic Dipeptides To Increase the Affinity toward Oligopeptide Transporter 1 for Enhanced Oral Absorption: An Application to Cyclo(l-Hyp-l-Ser) (JBP485).
Jiang Q; Zhang J; Tong P; Gao Y; Lv Y; Wang C; Luo M; Sun M; Wang J; Feng Y; Cao L; Wang G; Wang Y; Kan Q; Zhang T; Wang Y; Liu K; Sun J; He Z
J Med Chem; 2019 Sep; 62(17):7708-7721. PubMed ID: 31393124
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of JBP485 on concanavalin A-induced liver injury in mice.
Yang T; Wu J; Wang C; Liu Q; Ma X; Peng J; Kaku T; Liu K
J Pharm Pharmacol; 2009 Jun; 61(6):767-74. PubMed ID: 19505367
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and mechanism of intestinal absorption of JBP485 in rats.
Cang J; Zhang J; Wang C; Liu Q; Meng Q; Wang D; Sugiyama Y; Tsuji A; Kaku T; Liu K
Drug Metab Pharmacokinet; 2010; 25(5):500-7. PubMed ID: 20877133
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of three dipeptides (JBP485, Gly-Sar and JBP923) in the cell lysates by liquid chromatography-tandem mass spectrometry: application to identify the function of the PEPT1 transfected cell.
Guo X; Meng Q; Liu Q; Wang C; Huo X; Zhang Z; Kaku T; Liu K
Biomed Chromatogr; 2014 Dec; 28(12):1839-45. PubMed ID: 24903899
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of JBP485 on concanavalin A-induced hepatocyte toxicity in primary cultured rat hepatocytes.
Wu J; Wang C; Liu Q; Yang T; Zhang Q; Peng J; Gao Y; Sun H; Kaku T; Liu K
Eur J Pharmacol; 2008 Jul; 589(1-3):299-305. PubMed ID: 18571156
[TBL] [Abstract][Full Text] [Related]
8. Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells.
Wang W; Liu Q; Wang C; Meng Q; Kaku T; Liu K
Peptides; 2011 May; 32(5):946-55. PubMed ID: 21310202
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction between JBP485 and cephalexin in rats.
Zhang J; Wang C; Liu Q; Meng Q; Cang J; Sun H; Gao Y; Kaku T; Liu K
Drug Metab Dispos; 2010 Jun; 38(6):930-8. PubMed ID: 20219852
[TBL] [Abstract][Full Text] [Related]
10. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
[TBL] [Abstract][Full Text] [Related]
11. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of stable cyclic dipeptides by the oligopeptide transporter in rat.
Mizuma T; Masubuchi S; Awazu S
J Pharm Pharmacol; 1998 Feb; 50(2):167-72. PubMed ID: 9530984
[TBL] [Abstract][Full Text] [Related]
13. H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.
Inui K; Okano T; Maegawa H; Kato M; Takano M; Hori R
J Pharmacol Exp Ther; 1988 Oct; 247(1):235-41. PubMed ID: 3171973
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo.
Ishiki Y; Ohnishi H; Muto Y; Matsumoto K; Nakamura T
Hepatology; 1992 Nov; 16(5):1227-35. PubMed ID: 1427661
[TBL] [Abstract][Full Text] [Related]
15. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
16. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
[TBL] [Abstract][Full Text] [Related]
17. Multiplicity of the H+-dependent transport mechanism of dipeptide and anionic beta-lactam antibiotic ceftibuten in rat intestinal brush-border membrane.
Iseki K; Sugawara M; Sato K; Naasani I; Hayakawa T; Kobayashi M; Miyazaki K
J Pharmacol Exp Ther; 1999 Apr; 289(1):66-71. PubMed ID: 10086988
[TBL] [Abstract][Full Text] [Related]
18. H(+)-coupled uphill transport of the dipeptide glycylsarcosine by bovine intestinal brush-border membrane vesicles.
Wolffram S; Grenacher B; Scharrer E
J Dairy Sci; 1998 Oct; 81(10):2595-603. PubMed ID: 9812265
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of potassium dichromate inhibits brush border membrane enzymes and alters anti-oxidant status of rat intestine.
Arivarasu NA; Fatima S; Mahmood R
Arch Toxicol; 2008 Dec; 82(12):951-8. PubMed ID: 18488194
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a thiodipeptide, L-phenylalanyl-Ψ[CS-N]-L-alanine, as a novel probe for peptide transporter 1.
Arakawa H; Saito S; Kanagawa M; Kamioka H; Yano K; Morimoto K; Ogihara T
Drug Metab Pharmacokinet; 2014; 29(6):470-4. PubMed ID: 25008848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
